Abbonarsi

Development models to predict complication and prognosis following liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension - 10/02/25

Doi : 10.1016/j.amjsurg.2024.116172 
Shilei Bai a, 1 , Yizhe Dai b, 1 , Pinghua Yang c, 1 , Zhengqing Lei d , Fuchen Liu e , Zhao Yang a , Fengwei Li a , Yong Xia b , Feng Shen b, , Kui Wang a,
a Department of Hepatic Surgery II, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, PR China 
b Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, PR China 
c Department of Biliary Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, PR China 
d Department of Hepatobiliary Surgery, Zhongda Hospital, Southeast University, School of Medicine, Nanjing, Jiangsu, PR China 
e Department of Hepatic Surgery III, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, PR China 

Corresponding author. Department of Hepatic Surgery II, the Eastern Hepatobiliary Surgery Hospital, Naval Medical University, No. 225, Changhai Road, Yangpu District, Shanghai, 200438, PR China.Department of Hepatic Surgery IIthe Eastern Hepatobiliary Surgery HospitalNaval Medical UniversityNo. 225Changhai RoadYangpu DistrictShanghai200438PR China⁎⁎Corresponding author. Department of Hepatic Surgery IV and Clinical Research Institute, the Eastern Hepatobiliary Surgery Hospital, Naval Medical University, 225 Changhai Road, Shanghai, 200433, PR China.Department of Hepatic Surgery IV and Clinical Research Institutethe Eastern Hepatobiliary Surgery HospitalNaval Medical University225 Changhai RoadShanghai200433PR China

Abstract

Background

Postoperative complications are potential factors influencing the prognosis of patients with HCC combined with CSPH. This study aims to explore the risk factors affecting the occurrence of postoperative complications, investigate potential factors influencing long-term prognosis in these patients, and establish predictive models.

Methods

From April 2018 to December 2021, a total of 190 patients with HCC combined with CSPH who underwent curative liver resection in our hospital were included, comprising 69 cases in the complication group and 121 cases in the non-complication group. LASSO-Logistic regression was employed to identify risk factors influencing postoperative complications and establish a predictive model. LASSO-Cox regression was used to determine prognostic factors for long-term outcomes in patients with HCC combined with CSPH and establish a predictive model.

Results

LASSO regression selected variables including ALBI grade, preoperative ascites, major hepatectomy, and portal vein occlusion time >15 ​min. These variables were incorporated into logistic regression (P ​< ​0.05) to establish a nomogram for predicting postoperative complications, with a C-index of 0.723. Results from the multivariable Cox regression analysis showed that postoperative complications, maximum tumor diameter, and microvascular invasion were risk factors for recurrence, while postoperative complications, maximum tumor diameter, microvascular invasion, and prealbumin were risk factors for overall survival. The C-index values for the respective nomograms were 0.635 and 0.734. The calibration curves and ROC curves demonstrated good performance for all three nomograms.

Conclusions

The three nomograms achieved optimal predictive performance for postoperative complications, recurrence, and overall survival in patients with HCC combined with CSPH undergoing curative resection.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

Perioperative management of HCC patient with CSPH is difficult and has more postoperative complications.
The occurrence of complications is related to portal vein occlusion time, ascites and major hepatectomy.
Prealbumin, maximum tumor diameter,MVI and complications affects the prognosis of patients.
Complications,MVI and maximum tumor diameter have correlation with tumor recurrence.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Hepatocellular carcinoma, Portal vein hypertension, Nomogram, Postoperative complications, Prognosis


Mappa


© 2025  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 241

Articolo 116172- marzo 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Economics of emergency laparoscopic cholecystectomy at an Australian tertiary centre in the post COVID-19 era
  • Raymond Hayler, Sam Hanna, Andrea Boerkamp, Yijun Gao, Sam T. Alhayo, Michael L. Talbot
| Articolo seguente Articolo seguente
  • REBOA in patients with high-grade liver injury may be associated with worse outcomes
  • Wei Huang, Naveen Balan, Feifei Jin, Yu Cheng Chiu, Demetrios Demetriades

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.